Login to Your Account

Merck's Hepatitis C Drug Gets FDA Approval

By Mari Serebrov

Monday, May 16, 2011
WASHINGTON – The FDA approved Merck & Co. Inc.'s Victrelis Friday as the first new chronic hepatitis C treatment in more than a decade.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription